Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Easterbrook

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|September 9, 1999
Chemokine receptor polymorphisms and human immunodeficiency virus disease progressionP J Easterbrook, T Rostron, N Ives, et al.
AIDS (London, England)|July 20, 2002
The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/mlPhilippa J Easterbrook, Natalie Ives, Anele Waters, et al.
AIDS (London, England)|February 1, 1997
Long-term survival in patients with advanced immunodeficiencyG Chêne, P J Easterbrook, E Juszczak, et al.
Clinical and Experimental Immunology|November 25, 2003
CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjectsM J Boaz, A Waters, S Murad, et al.
HIV Medicine|December 12, 2001
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?D A Moore, R L Goodall, N J Ives, et al.
AIDS (London, England)|May 23, 2014
The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapyJohn Stover, Chaitra Gopalappa, Mary Mahy, et al.
Immunology|April 21, 2004
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infectionAnnapurna Vyakarnam, David Sidebottom, Shahed Murad, et al.
AIDS (London, England)|May 23, 2014
Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failureGeorge W Rutherford, Andrew Anglemyer, Philippa J Easterbrook, et al.
International Journal of STD & AIDS|March 4, 2000
Mycoplasma species in rapid and slow HIV progressorsJ G Ainsworth, S Hourshid, P J Easterbrook, et al.
HIV Medicine|October 4, 2003
Epidemiological risk factors for hypersensitivity reactions to abacavirP J Easterbrook, A Waters, S Murad, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|September 9, 1999
Chemokine receptor polymorphisms and human immunodeficiency virus disease progressionP J Easterbrook, T Rostron, N Ives, et al.
AIDS (London, England)|July 20, 2002
The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/mlPhilippa J Easterbrook, Natalie Ives, Anele Waters, et al.
AIDS (London, England)|February 1, 1997
Long-term survival in patients with advanced immunodeficiencyG Chêne, P J Easterbrook, E Juszczak, et al.
Clinical and Experimental Immunology|November 25, 2003
CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjectsM J Boaz, A Waters, S Murad, et al.
HIV Medicine|December 12, 2001
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?D A Moore, R L Goodall, N J Ives, et al.
AIDS (London, England)|May 23, 2014
The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapyJohn Stover, Chaitra Gopalappa, Mary Mahy, et al.
Immunology|April 21, 2004
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infectionAnnapurna Vyakarnam, David Sidebottom, Shahed Murad, et al.
AIDS (London, England)|May 23, 2014
Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failureGeorge W Rutherford, Andrew Anglemyer, Philippa J Easterbrook, et al.
International Journal of STD & AIDS|March 4, 2000
Mycoplasma species in rapid and slow HIV progressorsJ G Ainsworth, S Hourshid, P J Easterbrook, et al.
HIV Medicine|October 4, 2003
Epidemiological risk factors for hypersensitivity reactions to abacavirP J Easterbrook, A Waters, S Murad, et al.
Pageof 17